Principal Securities, Inc. Agios Pharmaceuticals, Inc. Transaction History
Principal Securities, Inc.
- $4.44 Trillion
- Q4 2024
A detailed history of Principal Securities, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 25 shares of AGIO stock, worth $830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$830% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
243Shares Held
58.3MCall Options Held
431KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$189 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$161 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$117 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$80.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.82B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...